Search Within

Ellin Berman

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (14)
  3. Book Section (1)
  4. Conference Paper (1)
Groups
  1. Adult Leukemia (35)
  2. Center for Hematologic Malignancies (35)
  3. Department of Medicine (35)
  4. GSK Faculty (35)
  5. Hematologic Malignancies, Division of (35)
  6. Center for Molecular Imaging and Biotechnology (26)

More Groups

People
  1. David Scheinberg (15)
  2. Peter Maslak (15)
  3. Mark Weiss (10)
  4. Timothy Gee (10)
  5. Bayard Clarkson (9)
  6. Martin Tallman (8)

More People

Years
  1. 2023 (1)
  2. 2019 (2)
  3. 2018 (1)
  4. 2017 (1)
  5. 2016 (1)
  6. 2015 (1)

More Years

Publications
  1. Blood (17)
  2. Journal of Clinical Oncology (6)
  3. Leukemia (4)
  4. Blood Advances (1)
  5. Bone Marrow Transplantation (1)
  6. Critical Reviews in Oncology/Hematology (1)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. American Society of Clinical Oncology (6)
  3. Nature Publishing Group (5)
  4. American Association for Cancer Research (1)
  5. American Association for the Advancement of Science (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (35)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Interaction between myelodysplasia-related gene mutations and ontogeny in acute myeloid leukemia
    Journal Article

    McCarter, J. G. W.; Nemirovsky, D.; Famulare, C. A.; Farnoud, N.; Mohanty, A. S.; Stone-Molloy, Z. S.; Chervin, J.; Ball, B. J.; Epstein-Peterson, Z. D.; Arcila, M. E.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Overcoming adaptive therapy resistance in AML by targeting immune response pathways
    Meeting Abstract

    Melgar, K. M.; Jones, L. M.; Walker, M.; Bolanos, L. C.; Hueneman, K.; Wunderlich, M.; Jiang, J. K.; Wilson, K.; Zhang, X.; Sutter, P.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Overcoming adaptive therapy resistance in AML by targeting immune response pathways
    Journal Article

    Melgar, K.; Walker, M. M.; Jones, L. M.; Bolanos, L. C.; Hueneman, K.; Wunderlich, M.; Jiang, J. K.; Wilson, K. M.; Zhang, X.; Sutter, P.; more...
    Science Translational Medicine (2019)

    Fulltext@MSK | Save
  • Hsp90 inhibition disrupts JAK-STAT signaling and leads to reductions in splenomegaly in patients with myeloproliferative neoplasms
    Journal Article

    Hobbs, G. S.; Hanasoge Somasundara, A. V.; Kleppe, M.; Litvin, R.; Arcila, M.; Ahn, J.; McKenney, A. S.; Knapp, K.; Ptashkin, R.; Weinstein, H.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Molecular profiling in extramedullary acute myeloid leukemia reveals distinct subgroups defined by mutations in KIT and RUNX1
    Meeting Abstract

    Goldberg, A. D.; Farnoud, N.; Goldberger, C.; Patel, M.; Famulare, C.; Medina, J.; Rampal, R. K.; Levine, R. L.; Berman, E.; Zhang, Y.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Clinical relevant alterations identified by comprehensive genomic profiling can potentially improve therapeutic option and change prognosis in hematologic malignancies
    Meeting Abstract

    He, J.; Patel, M.; Phillip, I.; Bailey, M.; Berman, E.; Park, J. H.; Shukla, N. N.; Chung, S. S.; Castro-Malaspina, H.; Douer, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • AUY922, a Heat Shock Protein 90 (Hsp90) inhibitor, demonstrates activity in patients with myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Hobbs, G.; Litvin, R.; Ahn, J.; McKenney, A. S.; Mauro, M. J.; Tallman, M. S.; Berman, E.; Heaney, M. L.; Levine, R. L.; Rampal, R. K.
    Blood (2015)

    Fulltext@MSK | Save
  • Leukemias and myelodysplastic syndromes
    Book Section

    Watts, J. M.; Klimek, V. M.; Tallman, M. S.; Douer, D.; Olson, A. L.; Berman, E.; Intlekofer, A. M.; Zelenetz, A. D.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Chronic myeloid leukemia after adjuvant treatment for breast cancer: Is it therapy related?
    Meeting Abstract

    Kishtagari, A.; Bowman, I. A.; Tallman, M. S.; Douer, D.; Berman, E.; Maslak, P. G.; Brentjens, R. J.; Stein, E. M.
    Blood (2013)

    Fulltext@MSK | Save
  • High-dose cytarabine monotherapy versus intermediate or high-dose cytarabine in combination with other agents as second-line salvage therapy In patients with acute myeloid leukemia who did not respond to initial induction therapy
    Meeting Abstract

    Dang, T. O. T.; Hilden, P.; Devlin, S. M.; Rampal, R. K.; Levine, R. L.; Berman, E.; Klimek, V. M.; Adel, N. G.; Tallman, M. S.
    Blood (2013)

    Fulltext@MSK | Save